Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1998-08-27
2000-07-04
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
530300, 530317, A61K 5108, A61K 3812
Patent
active
060834811
ABSTRACT:
This invention relates to radiolabeled reagents that are scintigraphic imaging agents for imaging sites of thrombus formation in vivo, and methods for producing such reagents. Specifically, the invention relates to reagents each comprised of a specific binding compound, capable of binding to at least one component of a thrombus, covalently linked to a radiolabel-binding moiety. The invention provides these reagents, methods and kits for making such reagents, and methods for using such reagents labeled with technetium-99m to image thrombus sites in a mammalian body.
REFERENCES:
patent: 5443816 (1995-08-01), Zamora et al.
patent: 5785948 (1998-07-01), Itaya et al.
patent: 5843402 (1998-12-01), Stuttle
patent: 5879657 (1999-03-01), DeGrado et al.
patent: 5888970 (1999-03-01), Rajopadhye et al.
Dean Richard T.
Lister-James John
Dees Jos,e G.
Diatide, Inc.
Hartley Michael G.
McDaniels Patricia A.
LandOfFree
Thrombus imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombus imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombus imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1483242